Warren Sherman - Concepedia

Author

Warren Sherman

Icahn School of Medicine at Mount Sinai

Also Known As

Douglas W. Losordo, W Sherman, WARREN SHERMAN, WARREN T. SHERMAN, Warren Sherman

102

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

Icahn School of Medicine at Mount Sinai Mount Sinai Beth Israel Columbia University Irving Medical Center St. Luke's-Roosevelt Hospital Center Clinical Research Institute

About

Warren Sherman is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	27	3K
2	Public Health	5	5	254
3	Health Sciences	4	4	133
4	Engineering	1	1	148
5	Social Sciences	1	1	75

Warren Sherman

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction Joshua M. Hare, Jay H. Traverse, Timothy D. Henry, Journal of the American College of Cardiology Regenerative MedicineDose-escalation StudyStem CellsAdult Stem CellStem Cell Research	2009	1.3K
Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction Simon Dixon, Thanh T. Nguyen, William W. O’Neill, Journal of the American College of Cardiology Percutaneous Coronary InterventionCardiogenic ShockHyperthermiaCardiovascular DiseaseThermal Therapy	2002	313
Cardiopoietic cell therapy for advanced ischemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial Jozef Bartúnek, André Terzic, Beth A. Davison, European Heart Journal	2016	180
Percutaneous Cell Delivery into the Heart Using Hydrogels Polymerizing in Situ Timothy P. Martens, Amandine F. G. Godier, Jonathan Parks, Cell Transplantation Tissue EngineeringCatheter DeliveryEngineeringBiomaterials DesignCardiac Regeneration	2009	148
An Open-Label Dose Escalation Study to Evaluate the Safety of Administration of Nonviral Stromal Cell-Derived Factor-1 Plasmid to Treat Symptomatic Ischemic Heart Failure Marc S. Penn, Farrell O. Mendelsohn, Gary L. Schaer, Circulation Research	2013	132
Determinants of collateral filling observed during sudden controlled coronary artery occlusion in human subjects Marc Cohen, Warren Sherman, K.Peter Rentrop, Journal of the American College of Cardiology Cardiovascular DiseaseAtherosclerosisMyocardial InfarctionCoronary Artery DiseaseHuman Subjects	1989	127
Adventitial Delivery of an Allogeneic Bone Marrow–Derived Adherent Stem Cell in Acute Myocardial Infarction Marc S. Penn, Stephen G. Ellis, Sanjay Gandhi, Circulation Research	2011	114
A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction Thomas J. Povsic, Christopher M. O’Connor, Timothy D. Henry, American Heart Journal Regenerative MedicineSkeletal Myoblast ImplantationCatheter DeliveryHeart FailureChronic Heart Failure	2011	103
Late thrombolytic therapy preserves left ventricular function in patients with collateralized total coronary occlusion: Primary end point findings of the second mount sinai-new york university reperfusion trial K.Peter Rentrop, Frederick Feit, Warren Sherman, Journal of the American College of Cardiology ThrombosisCardiovascular DiseaseAcute Myocardial InfarctionMedicineCardiology	1989	101
Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials Timothy D. Henry, Douglas W. Losordo, Jay H. Traverse, European Heart Journal	2017	101

Page 1